Vimseltinib | Inhibitor of CSF1R
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Control Compounds

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
CSF1R
  • IC50:4.2 nM @ 4 mM ATP
  • IC50:19 nM
  • IC50:9.2 nM
Inhibitor
1 µM

Selectivity

In Vitro Selectivity Assessment
KIT

Gene ID: P10721

Organism: Homo sapiens

Family: Tyr protein kinase family

Potency: IC50 - 1600 nM

Potency Assay Off-Target:
Vimseltinib was profiled versus a total of approximately 300 human kinases at 10 mM ATP. Kinases inh ...
Selectivity Assessment Description:
Vimseltinib was >100-fold selective for CSF1R versus all kinases tested and >1,000-fold selective fo ...

Potency
Cellular
In Vitro

CSF1R

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1158/1535-7163.MCT-21-0361

In Vivo Validations

Mouse
Dose: 10 mg/Kg
Route of delivery: Oral
Plasma half life: 11.1 h
Systemic clearance: 0.046 L/h/Kg
Cmax: 10738 ng/mL
Tmax: 6 h
Area Under the Curve:: 170035 ng*h/mL
Volume of Distribution at Steady-State: 0.731 L/Kg

DOI Reference: 10.1158/1535-7163.MCT-21-0361

Dose: 3 mg/Kg
Route of delivery: Oral
Plasma half life: 8.96 h
Systemic clearance: 0.052 L/h/Kg
Cmax: 3226 ng/mL
Tmax: 6 h
Area Under the Curve:: 49314 ng*h/mL
Volume of Distribution at Steady-State: 0.661 L/Kg

DOI Reference: 10.1158/1535-7163.MCT-21-0361

Dose: 1 mg/Kg
Route of delivery: Oral
Plasma half life: 9.07 h
Systemic clearance: 0.057 L/h/Kg
Cmax: 1121 ng/mL
Tmax: 2 h
Area Under the Curve:: 14625 ng*h/mL
Volume of Distribution at Steady-State: 0.744 L/Kg

DOI Reference: 10.1158/1535-7163.MCT-21-0361

Orthogonal Probes def

PEXIDARTINIB
AC710

Chemical Information

Molecular Formula C23H25N7O2
SMILEs Cc1nc(-c2cnc(NC(C)C)n(C)c2=O)ccc1Oc1ccnc(-c2cnn(C)c2)c1
InChI InChI=1S/C23H25N7O2/c1-14(2)27-23-25-12-18(22(31)30(23)5)19-6-7-21(15(3)28-19)32-17-8-9-24-20(10-17)16-11-26-29(4)13-16/h6-14H,1-5H3,(H,25,27)
Molecular weight 431.21 Da
AlogP 0.0
HBond acceptors 9
HBond donors 1
Atoms 57

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


No SERP comments found for Vimseltinib

Probe Vimseltinib is in the process of SERP review.

Please continue to check back for new reviews and commentary.